|
|
Using zebrafish, researchers at the University of Pittsburgh have identified and described an enzyme inhibitor that allows them to increase the number of cardiac progenitor cells and therefore influence the size of the developing heart. The findings are described in the advance online version of Nature Chemical Biology. The zebrafish model has powerful advantages for studying embryonic development, said senior author Michael Tsang, Ph.D., assistant professor, Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine. "This gives us a better understanding of heart development during the embryonic stage and has implications for adult disease," he noted. "As we try to create treatments that restore normal function to damaged or diseased tissues, it will help us to know the biologic pathways... [read full story]
November 25, 2009 by Suzanne Morrison (PhysOrg.com) -- A McMaster University-led research team has developed an innovative software tool that gives family doctors up-to-date information on their patients in two seconds or less....
Tasty and Nutritious - And No Bad Breath! Here are two appealing recipes that combine spinach with copious amounts of sautéed garlic and other healthy ingredients such as raisins, pine nuts, or tomatoes. The repertoire of...
Enlarge Saturn's moon Prometheus, orbiting near the streamer-channels it has created in the thin F ring, casts a shadow on the A ring in this image taken a little more than a week after the planet's August 2009 equinox. Image...
SAN FRANCISCO (AP) - Global Defense Technology & Systems Inc. said Wednesday that it closed its initial public offering of 4.6 million common shares, which were priced at $13 apiece and yielded $36.3 million in net proceeds....
